Be the first to know about every new Coronavirus story

The EU drug regulator will launch an investigation into Russia’s Covid-19 shot

The EU drug regulator will launch an investigation next week into whether clinical trials of Russia’s Sputnik V Covid-19 vaccine contravened ethical standards, and Japan’s national champion, Renesas Electronics, is being forced to diversify due to the pressures brought on by the chip industry. Plus, the FT’s Latin America editor, Michael Stott, explains how president Jair Bolsonaro lost his grip of Brazil. 

EU regulator to probe ethical standards of Sputnik vaccine trials

Chip industry pressures spur Renesas to diversify

Brazil’s coronavirus nightmare: ‘Bolsonaro is more isolated than ever’

Nematodes the latest casualty of post-Brexit trade glitches

See for privacy and opt-out information.

A transcript for this podcast is currently unavailable, view our accessibility guide.

Get alerts on FT News Briefing when a new story is published

Copyright The Financial Times Limited 2021. All rights reserved.
Reuse this content (opens in new window)

Comments have not been enabled for this podcast.

Follow the topics in this podcast